These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15004940)

  • 1. [Macroprolactinemia. Risk of misdiagnosis and mismanagement in hyperprolactinemia].
    Valdemarsson S
    Lakartidningen; 2004 Feb; 101(6):458-65. PubMed ID: 15004940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroprolactin(s): composition and reactivity in immunoassays and laboratory interpretation of results of an unusual patient serum.
    Ellis AR; Fahie-Wilson M; Axcell M; Sands K; Hill RP
    Ann Clin Biochem; 2006 Jan; 43(Pt 1):57-62. PubMed ID: 16390610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
    Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
    Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM; Smith TP; Gibney J; McKenna TJ
    Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology insight: measuring prolactin in clinical samples.
    Smith TP; Kavanagh L; Healy ML; McKenna TJ
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):279-89. PubMed ID: 17315036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of prolactin: the macroprolactin problem.
    Fahie-Wilson M; Smith TP
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Macroprolactinemia, a benign form of hyperprolactinemia].
    Vos MC; Land JA; Menheere PP; Evers JL
    Ned Tijdschr Geneeskd; 2001 May; 145(20):967-70. PubMed ID: 11396264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
    Overgaard M; Pedersen SM
    Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Macroprolactinaemia].
    Kostrzak A; Meczekalski B
    Pol Merkur Lekarski; 2010 Jul; 29(169):47-9. PubMed ID: 20712249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactin; high molecular mass forms of circulating prolactin.
    Fahie-Wilson MN; John R; Ellis AR
    Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.
    Amadori P; Dilberis C; Marcolla A; Pinamonti M; Menapace P; Dal Bosco F
    J Endocrinol Invest; 2003 Feb; 26(2):148-56. PubMed ID: 12739743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
    Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.
    Whitehead SJ; Cornes MP; Ford C; Gama R
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroprolactinemia in a patient with infertility and hyperprolactinemia.
    Khandwala HM
    South Med J; 2006 Nov; 99(11):1282-4. PubMed ID: 17195425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
    Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
    Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and macroprolactin: a case report of hyperprolactinaemia highlighting the interpretation of discrepant results.
    Ismail AA; Walker PL; Fahie-Wilson MN; Jassam N; Barth JH
    Ann Clin Biochem; 2003 May; 40(Pt 3):298-300. PubMed ID: 12803849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.